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Diminished salivary epidermal growth factor secretion: a link between
Sjögren’s syndrome and autoimmune gastritis?
K Koskenpato1,2, M Ainola1, B Przybyla1, V-P Kouri1, L Virkki1, J Koskenpato3,4, A Ristimäki4,5, YT Konttinen1,4,6*
Departments of 1Medicine, 2Anatomy, and 3Gastroenterology, University of Helsinki, 4Helsinki University Central Hospital,
5Department of Pathology, University of Helsinki, and 6ORTON Orthopaedic Hospital, ORTON Foundation, Helsinki, Finland
Objectives: Healthy human labial salivary glands produce epidermal growth factor (EGF). In Sjögren’s syndrome
(SS), EGF staining is diminished. SS is also associated with chronic autoimmune corpus gastritis. We therefore
hypothesized that EGF secretion would be diminished in SS and that this could affect gastric target cells.
Methods: Salivary EGF secretion in SS was compared to that in healthy controls using an enzyme-linked immuno-
sorbent assay (ELISA). EGF receptor (EGFR) immunoreactive cells in the gastric corpus of healthy human subjects
were analysed using immunostaining.
Results: Salivary secretion of EGF was diminished in SS patients (232.4, range 52.6–618.4, vs. 756.6, range 105.3–
1631.6 pg/min, p = 0.002). Proton-pump positive parietal cells were mostly EGFR immunoreactive whereas very few
pepsinogen I (PGI)-positive cells were EGFR positive.
Conclusions: As EGF is relatively acid resistant, salivary gland-derived EGF might participate in an exo/endocrine
mode of parietal cell maintenance in the gastric corpus. Deﬁciency of salivary gland-derived EGF in SS patients may
cause impairment of gastric parietal cells resulting in exposure of immunogenic cryptic antigens and loss of
immunological self-tolerance.
Epidermal growth factor (EGF) is found in many human
secretions, including plasma, urine, and gastric juice,
but particularly in saliva (1, 2). EGF binding to the
EGF receptor (EGFR) on cell surfaces regulates epithe-
lial cell proliferation, adhesion/migration, and survival.
EGF has been shown to protect gastric mucosa from
various intraluminal injurious factors, such as gastric
acid and pepsin (3, 4). Of interest, no EGF mRNA or
protein has been found in healthy gastric tissues (5, 6).
This implies that EGF found in gastric juice originates
from other tissues, possibly from salivary glands. The
concentration of EGF in saliva is ~6–7-fold higher than
in gastric juice (2) and more than 50-fold higher than in
plasma (1), suggesting production of EGF in saliva ‘for
export’.
We have previously described chronic autoimmune
corpus gastritis in patients with Sjögren’s syndrome (SS)
(7). This ﬁnding was later conﬁrmed in another study (8).
Chronic autoimmune gastritis is restricted to the gastric
body. This agrees with a relatively high prevalence of
parietal cell-speciﬁc autoantibodies in SS (9), whose
main target is the gastric H+/K+ ATPase (10).
Healthy human salivary glands stain for EGF but
staining is diminished in patients with SS (11). We
therefore hypothesized that, in SS, a diminished salivary
ﬂow would lead to a diminished and disturbed EGF
secretion. Because of the association between SS and
autoimmune gastritis, we further hypothesized that par-
ietal cells located in the gastric corpus are potential
target cells of salivary EGF.
Method
Patients and samples
Stimulated saliva was collected from 28 females diag-
nosed with primary SS (age range 38–78; median
55.5 years) and from 12 healthy, female controls
(age range 22–55; median 52.0 years). The age
difference between the groups was signiﬁcant
(p = 0.01). Patients with primary SS fulﬁlled the
American–European criteria (12). Healthy controls
were employees of Biomedicum Helsinki and were
in general good health (self-reported). Stimulated
whole saliva samples were collected by chewing a
piece of hard parafﬁn for 5 min, the samples centri-
fuged, and cell-free supernatants were stored at
−70°C with proteinase inhibitors (1:25, Roche,
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Basel, Switzerland). The total protein content was
measured using the Bradford assay.
Multiple gastric biopsies were obtained from seven
patients (age range 38–83; median 63.0 years) under-
going diagnostic gastroscopy without any abnormality
in clinical examination and with normal ﬁndings in
the histological evaluation of the biopses. Samples
were ﬁxed in 10% buffered formaldehyde and
embedded in parafﬁn.
The ethics committee of the Hospital District of Hel-
sinki and Uusimaa approved the study (Dnr 19/E5/03)
and the use of earlier collected gastric mucosal biopsies
for this study (Dnr 44/13/03/01/2013).##
EGF enzyme-linked immunosorbent assay (ELISA)
EGF concentrations in whole mixed saliva were mea-
sured using an ELISA (DEG00, R&D, Minneapolis,
MN, USA) according to the manufacturer’s instructions.
Samples were diluted 1:15 and tested in duplicate.
Double immunohistochemical staining
Four-micrometre-thick sections were stained using a fully
automated Leica Bond-Max immunostainer (Leica Micro-
systems, Wetzlar, Germany). Double immunostaining was
performed in a consecutive manner using two detection
systems: horseradish peroxidase (HRP)-based Bond Poly-
mer Reﬁne (DS9800) and alkaline phosphate (AP)-based
Bond Polymer Reﬁne Red (DS9390). Antigens were
retrieved in Epitope Retriaval solution 2 (Leica Microsys-
tems) for 20 min. The slides were incubated with primary
antibodies for 30 min. The following primary antibodies
were used: mouse anti-human H+/K+ ATPase β-subunit
IgG1 (0.125 μg/mL, Clone 2B6, Fitzgerald, MA, USA;
n = 3), pepsinogen I (PGI) IgG1 (0.05 μg/mL, Clone
4C6.1, Biohit Oyj, Helsinki, Finland; n = 6), and rabbit
anti-human EGFR IgG (1:100, Epitomics, Burlingame,
CA, USA). Control non-immune rabbit IgG and mouse
IgG1 were used at the same concentrations as the primary
antibodies.
Double immunoﬂuorescence staining
Antigens were retrieved in 10 mM citrate buffer with
0.05% Triton X, pH 6.0, using a MicroMED microwave
oven for 24 min at +98°C (Milestone Srl, Sorisole,
Italy). Samples were blocked in 10% normal goat
serum for 1 h and incubated with 0.5 μg/mL mouse
anti-human H+/K+ ATPase β-subunit and with 1:50
diluted rabbit anti-human EGFR overnight at +4°C.
Secondary Alexa Fluor 488-conjugated goat anti-
mouse IgG and Alexa Fluor 568-conjugated goat anti-
rabbit IgG (Molecular Probes, Leiden, The Netherlands)
were applied for 1 h at room temperature. Nuclei
were counterstained with 4ʹ,6-diamidino-2-phenylindole
(DAPI). Negative staining controls were as described
earlier.
Statistical analysis
The differences between groups were investigated with
the Mann–Whitney U-test using IBM SPSS version 21.
p-values < 0.05 were considered statistically signiﬁcant.
Results
EGF in saliva
Salivary secretion was signiﬁcantly diminished in SS
patients (median 0.67 mL/min, range 0.06–3.00 mL/
min) compared to controls (median 1.75 mL/min,
range 0.90–2.70 mL/min). The protein concentration
(w/v) of whole mixed saliva was signiﬁcantly higher
in SS (median 0.86 mg/mL, range 0.40–3.54 mg/mL)
than in controls (median 0.68 mg/mL, range 0.37–
1.21 mg/mL) but the protein secretion (mg/min) was
signiﬁcantly lower in SS (median 0.66 mg/min, range
0.05–2.36 pg/min) than in controls (median 1.09 mg/
min, range 0.40–2.13 mg/min).
EGF concentration (w/v) in SS (median 273.6 pg/mL,
range 57.45–2074.5 pg/mL) was not signiﬁcantly dif-
ferent from controls (median 381.2 pg/mL, range 88.5–
673.2 pg/mL). There was also no signiﬁcant difference
in EGF concentration per mg salivary protein between
SS (median 328.1 pg/mg, range 91.9–4943.4 pg/mg)
and controls (median 598.6 pg/mg, range 111.9–
1082.6 pg/mL). EGF secretion was signiﬁcantly lower
(p = 0.002) in SS (median 232.4 pg/min, range 52.6–
618.4 pg/min) than in controls (median 756.6 pg/min,
range 105.3–1631.6 pg/min) (Figure 1).
In SS patients, EGF secretion was not signiﬁcantly
correlated with total protein secretion (r = 0.19;
SS patients
0
500
EG
F,
 p
g/
m
in
1000
1500
2000
Healthy controls
Figure 1. Box plot showing epidermal growth factor (EGF) secretion
(pg/min) in patients with Sjögren’s syndrome (SS) and healthy
controls.
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p = 0.33) or with age (r = −0.167; p = 0.395), while in
healthy controls there was a tendency for correlation of
EGF secretion with total protein concentration
(r = 0.435; p = 0.157) and with age (r = 0.436;
p = 0.156).
Double staining of a parietal cell marker and EGFR
Immunohistochemical double staining of H+/K+
ATPase and EGFR disclosed an overlapping staining
pattern. Most H+/K+ ATPase immunoreactive parietal
cells were also EGFR immunoreactive and EGFR stain-
ing was stronger at the basolateral plasma membrane
(Figure 2A). Immunoﬂuorescence supported these
ﬁndings by showing similar results to EGFR immunor-
eactivity surrounding H+/K+ ATPase immunoreactive
parietal cells (Figure 2B).
Double staining of a chief cell marker and EGFR
Immunohistochemical double staining of PGI and EGFR
revealed that most PGI immunoreactive cells were EGFR
negative (Figure 3A). This double staining also revealed
that many PGI negative (parietal) cells were EGFR
immunoreactive, in particular at the basolateral plasma
membrane (Figure 3A). Very few, weakly PGI positive
(chief) cells were found to be EGFR positive
(Figure 3B).
A B
Figure 3. Immunohistochemical staining showing (A) pepsinogen I (PGI) immunoreactive chief cells (brown) and epidermal growth factor receptor
(EGFR, red). Some double-positive cells have been marked with arrowheads. PGI negative cells are EGFR immunoreactive. Original magniﬁcation
×100. (B) PGI immunoreactive chief cells (brown) and EGFR (red). Arrowheads point at some cells that are weakly stained for PGI and that are
EGFR immunoreactive. Original magniﬁcation ×200.
A B
Figure 2. (A) Immunohistochemical staining showing H+/K+ ATPase immunoreactive parietal cells (brown) and epidermal growth factor receptor
(EGFR, red). Some double-positive cells have been marked with arrowheads. The H+/K+ ATPase negative cells are also EGFR negative. (B)
Double immunoﬂuorescence staining showing H+/K+ ATPase immunoreactive parietal cells (green) and EGFR (red). Some double-positive cells
have been marked with arrowheads. Original magniﬁcation ×200.
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Discussion
Sjögren’s syndrome is an autoimmune epithelitis charac-
terized by dry eyes (keratoconjunctivitis sicca) and dry
mouth (xerostomia). The presence of focal lymphoplas-
macytoid sialadenitis and/or SSA/Ro or SSB/La autoanti-
bodies is required for diagnosis (12). Diminished
production of saliva in SS may lead to diminished secre-
tion of salivary gland-derived proteins and also impair the
quality of saliva. In this study we show that salivary EGF
secretion is diminished in SS, a result that is compatible
with earlier ﬁndings (11, 13). The absence of any correla-
tion between EGF and total protein secretion indicates that
the decline in EGF in SS is not just a consequence of
diminished overall protein secretion. Salivary EGF secre-
tion is shown to increase with age (14), a ﬁnding that is
conﬁrmed by the results in our control group. Therefore, a
difference in age between SS patients and the controls in
our study cannot explain the diminished EGF secretion in
SS. The correlation between age and EGF secretion is lost
in SS, which may indicate disease progression as a deter-
mining factor.
H+/K+ ATPase is a marker for parietal cells, which
produce gastric acid, whereas PGI is a marker for chief
cells. H+/K+ ATPase/EGFR double staining results suggest
that most parietal cells express EGFR and that most of the
proton pump-negative cells, probably chief cells, are EGFR
negative. In the PGI/EGFR double staining, most of the
PGI negative cells, probably parietal cells, were EGFR
immunoreactive. However, someweakly PGI immunoreac-
tive cells were also EGFR positive. The reciprocal staining
pattern in these two double staining experiments clearly
establishes the parietal cells as EGFR positive cells and as
a potential target for salivary EGF. The labelled polymer
method used in this study bypasses the potential pitfalls
such as immunologically non-speciﬁc labelling of parietal
cells due to avidin–lectin (6) and streptavidin–RGD integrin
(3) interactions. Although an exocrine and intraluminal
mode of action has been suggested for salivary EGF (3),
EGFR staining in this study showed more prominent baso-
lateral than apical parietal localization of EGFR positive
cell membranes.
We speculated that, in SS, the decrease in salivary EGF
production and transient parietal cell action may lead to
premature and abnormal apoptosis of the mature acid-pro-
ducing, non-dividing, and migrating parietal cells resulting
in a display of cryptic and immunogenic antigenic determi-
nants. Proton pump-directed immune reactivity is patho-
genic in arious experimental autoimmune gastritis models
(15). Similarly, lack of central tolerance in autoimmune
polyendocrinopathy type 1 or loss of peripheral tolerance
in SS might play a role in autoimmune gastritis. In this
study we propose a mechanism underlying the autoimmune
gastritis in SS; however, additional studies in gastric tissue
of SS patients are needed to support this hypothesis. In
conclusion, diminished EGF secretion for export might
form a link explaining the association observed between
autoimmune corpus gastritis and SS.
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